INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells
Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival f...
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 2012-04, Vol.72 (8), p.2006-2016 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2016 |
---|---|
container_issue | 8 |
container_start_page | 2006 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 72 |
creator | MORRIS, Christelle TOMIMATSU, Nozomi RICHARD, Derek J CLUET, David BURMA, Sandeep KUM KHANNA, Kum JALINOT, Pierre |
description | Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G(2)-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response. |
doi_str_mv | 10.1158/0008-5472.CAN-11-2562 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3335344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1020842813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-c3a2f867630454910004847d4c42f5b549ca54ae98f5bf2e3885416f99e34b603</originalsourceid><addsrcrecordid>eNpdkV1v0zAUhi0EYmXwE0C-QZqQsvkzcW6Qoq5bI5UyTeXact2TNSixOzsZ8O9x1a58XFnn-Hnf4-MXofeUXFIq1RUhRGVSFOxyWi0zSjMmc_YCTajkKiuEkC_R5MScoTcxfk-lpES-RmeMSaLyspigrl6u8qtZfcNnuHYDBGOHiH-0wxZXqy_YuA2uI76Hx7ENsMGND_gu-B0EPPsJdhxa77Bv8LAFfL2s8LXpzQMkPu68i4Bbh-djbxyeQtfFt-hVY7oI747nOfp2M1tN59ni6209rRaZlaQcMssNa1Re5JwIKUqa3i2UKDbCCtbIdWpZI4WBUqWqYcCVkoLmTVkCF-uc8HP0-eC7G9c9bCy4IZhO70Lbm_BLe9Pqf29cu9UP_klzziUXIhl8Ohhs_5PNq4UGFzudfpYUBRNPNMEXx2nBP44QB9230aZ9jQM_Rk0JI0owRXlC5QG1wccYoDmZU6L3sep9ZHofmU6xppbex5p0H_5e6KR6zjEBH4-AidZ0TTDOtvEPJxWlghT8N9qZp_M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1020842813</pqid></control><display><type>article</type><title>INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>MORRIS, Christelle ; TOMIMATSU, Nozomi ; RICHARD, Derek J ; CLUET, David ; BURMA, Sandeep ; KUM KHANNA, Kum ; JALINOT, Pierre</creator><creatorcontrib>MORRIS, Christelle ; TOMIMATSU, Nozomi ; RICHARD, Derek J ; CLUET, David ; BURMA, Sandeep ; KUM KHANNA, Kum ; JALINOT, Pierre</creatorcontrib><description>Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G(2)-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-11-2562</identifier><identifier>PMID: 22508697</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Ataxia telangiectasia mutated protein ; Ataxia Telangiectasia Mutated Proteins ; Biological and medical sciences ; BRCA1 protein ; BRCA1 Protein - metabolism ; Breast cancer ; Cancer ; Carcinogenesis ; Cell Cycle Checkpoints ; Cell Cycle Proteins - metabolism ; Cell Line, Tumor ; Cell Survival ; Cell Transformation, Neoplastic - metabolism ; CHK1 protein ; DNA damage ; DNA Damage - physiology ; DNA repair ; DNA-Binding Proteins - metabolism ; Drugs ; Eukaryotic Initiation Factor-3 - metabolism ; Fluorescent Antibody Technique ; Gene Knockdown Techniques ; Humans ; Immunoblotting ; Immunoprecipitation ; Initiation factors ; INT6 gene ; Life Sciences ; Medical sciences ; Microscopy, Confocal ; Pharmacology. Drug treatments ; Phosphorylation ; Protein-Serine-Threonine Kinases - metabolism ; RNA ; RNA-mediated interference ; Translation ; Tumor Suppressor Proteins - metabolism ; Tumors ; Ubiquitin</subject><ispartof>Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8), p.2006-2016</ispartof><rights>2015 INIST-CNRS</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-c3a2f867630454910004847d4c42f5b549ca54ae98f5bf2e3885416f99e34b603</citedby><cites>FETCH-LOGICAL-c509t-c3a2f867630454910004847d4c42f5b549ca54ae98f5bf2e3885416f99e34b603</cites><orcidid>0000-0002-9836-6849</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3356,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25811407$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22508697$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://ens-lyon.hal.science/ensl-00807724$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>MORRIS, Christelle</creatorcontrib><creatorcontrib>TOMIMATSU, Nozomi</creatorcontrib><creatorcontrib>RICHARD, Derek J</creatorcontrib><creatorcontrib>CLUET, David</creatorcontrib><creatorcontrib>BURMA, Sandeep</creatorcontrib><creatorcontrib>KUM KHANNA, Kum</creatorcontrib><creatorcontrib>JALINOT, Pierre</creatorcontrib><title>INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G(2)-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response.</description><subject>Antineoplastic agents</subject><subject>Ataxia telangiectasia mutated protein</subject><subject>Ataxia Telangiectasia Mutated Proteins</subject><subject>Biological and medical sciences</subject><subject>BRCA1 protein</subject><subject>BRCA1 Protein - metabolism</subject><subject>Breast cancer</subject><subject>Cancer</subject><subject>Carcinogenesis</subject><subject>Cell Cycle Checkpoints</subject><subject>Cell Cycle Proteins - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival</subject><subject>Cell Transformation, Neoplastic - metabolism</subject><subject>CHK1 protein</subject><subject>DNA damage</subject><subject>DNA Damage - physiology</subject><subject>DNA repair</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Drugs</subject><subject>Eukaryotic Initiation Factor-3 - metabolism</subject><subject>Fluorescent Antibody Technique</subject><subject>Gene Knockdown Techniques</subject><subject>Humans</subject><subject>Immunoblotting</subject><subject>Immunoprecipitation</subject><subject>Initiation factors</subject><subject>INT6 gene</subject><subject>Life Sciences</subject><subject>Medical sciences</subject><subject>Microscopy, Confocal</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphorylation</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>RNA</subject><subject>RNA-mediated interference</subject><subject>Translation</subject><subject>Tumor Suppressor Proteins - metabolism</subject><subject>Tumors</subject><subject>Ubiquitin</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV1v0zAUhi0EYmXwE0C-QZqQsvkzcW6Qoq5bI5UyTeXact2TNSixOzsZ8O9x1a58XFnn-Hnf4-MXofeUXFIq1RUhRGVSFOxyWi0zSjMmc_YCTajkKiuEkC_R5MScoTcxfk-lpES-RmeMSaLyspigrl6u8qtZfcNnuHYDBGOHiH-0wxZXqy_YuA2uI76Hx7ENsMGND_gu-B0EPPsJdhxa77Bv8LAFfL2s8LXpzQMkPu68i4Bbh-djbxyeQtfFt-hVY7oI747nOfp2M1tN59ni6209rRaZlaQcMssNa1Re5JwIKUqa3i2UKDbCCtbIdWpZI4WBUqWqYcCVkoLmTVkCF-uc8HP0-eC7G9c9bCy4IZhO70Lbm_BLe9Pqf29cu9UP_klzziUXIhl8Ohhs_5PNq4UGFzudfpYUBRNPNMEXx2nBP44QB9230aZ9jQM_Rk0JI0owRXlC5QG1wccYoDmZU6L3sep9ZHofmU6xppbex5p0H_5e6KR6zjEBH4-AidZ0TTDOtvEPJxWlghT8N9qZp_M</recordid><startdate>20120415</startdate><enddate>20120415</enddate><creator>MORRIS, Christelle</creator><creator>TOMIMATSU, Nozomi</creator><creator>RICHARD, Derek J</creator><creator>CLUET, David</creator><creator>BURMA, Sandeep</creator><creator>KUM KHANNA, Kum</creator><creator>JALINOT, Pierre</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9836-6849</orcidid></search><sort><creationdate>20120415</creationdate><title>INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells</title><author>MORRIS, Christelle ; TOMIMATSU, Nozomi ; RICHARD, Derek J ; CLUET, David ; BURMA, Sandeep ; KUM KHANNA, Kum ; JALINOT, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-c3a2f867630454910004847d4c42f5b549ca54ae98f5bf2e3885416f99e34b603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antineoplastic agents</topic><topic>Ataxia telangiectasia mutated protein</topic><topic>Ataxia Telangiectasia Mutated Proteins</topic><topic>Biological and medical sciences</topic><topic>BRCA1 protein</topic><topic>BRCA1 Protein - metabolism</topic><topic>Breast cancer</topic><topic>Cancer</topic><topic>Carcinogenesis</topic><topic>Cell Cycle Checkpoints</topic><topic>Cell Cycle Proteins - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival</topic><topic>Cell Transformation, Neoplastic - metabolism</topic><topic>CHK1 protein</topic><topic>DNA damage</topic><topic>DNA Damage - physiology</topic><topic>DNA repair</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Drugs</topic><topic>Eukaryotic Initiation Factor-3 - metabolism</topic><topic>Fluorescent Antibody Technique</topic><topic>Gene Knockdown Techniques</topic><topic>Humans</topic><topic>Immunoblotting</topic><topic>Immunoprecipitation</topic><topic>Initiation factors</topic><topic>INT6 gene</topic><topic>Life Sciences</topic><topic>Medical sciences</topic><topic>Microscopy, Confocal</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphorylation</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>RNA</topic><topic>RNA-mediated interference</topic><topic>Translation</topic><topic>Tumor Suppressor Proteins - metabolism</topic><topic>Tumors</topic><topic>Ubiquitin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MORRIS, Christelle</creatorcontrib><creatorcontrib>TOMIMATSU, Nozomi</creatorcontrib><creatorcontrib>RICHARD, Derek J</creatorcontrib><creatorcontrib>CLUET, David</creatorcontrib><creatorcontrib>BURMA, Sandeep</creatorcontrib><creatorcontrib>KUM KHANNA, Kum</creatorcontrib><creatorcontrib>JALINOT, Pierre</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MORRIS, Christelle</au><au>TOMIMATSU, Nozomi</au><au>RICHARD, Derek J</au><au>CLUET, David</au><au>BURMA, Sandeep</au><au>KUM KHANNA, Kum</au><au>JALINOT, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2012-04-15</date><risdate>2012</risdate><volume>72</volume><issue>8</issue><spage>2006</spage><epage>2016</epage><pages>2006-2016</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G(2)-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>22508697</pmid><doi>10.1158/0008-5472.CAN-11-2562</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9836-6849</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8), p.2006-2016 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3335344 |
source | MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals |
subjects | Antineoplastic agents Ataxia telangiectasia mutated protein Ataxia Telangiectasia Mutated Proteins Biological and medical sciences BRCA1 protein BRCA1 Protein - metabolism Breast cancer Cancer Carcinogenesis Cell Cycle Checkpoints Cell Cycle Proteins - metabolism Cell Line, Tumor Cell Survival Cell Transformation, Neoplastic - metabolism CHK1 protein DNA damage DNA Damage - physiology DNA repair DNA-Binding Proteins - metabolism Drugs Eukaryotic Initiation Factor-3 - metabolism Fluorescent Antibody Technique Gene Knockdown Techniques Humans Immunoblotting Immunoprecipitation Initiation factors INT6 gene Life Sciences Medical sciences Microscopy, Confocal Pharmacology. Drug treatments Phosphorylation Protein-Serine-Threonine Kinases - metabolism RNA RNA-mediated interference Translation Tumor Suppressor Proteins - metabolism Tumors Ubiquitin |
title | INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A15%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=INT6/EIF3E%20Interacts%20with%20ATM%20and%20Is%20Required%20for%20Proper%20Execution%20of%20the%20DNA%20Damage%20Response%20in%20Human%20Cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=MORRIS,%20Christelle&rft.date=2012-04-15&rft.volume=72&rft.issue=8&rft.spage=2006&rft.epage=2016&rft.pages=2006-2016&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-11-2562&rft_dat=%3Cproquest_pubme%3E1020842813%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1020842813&rft_id=info:pmid/22508697&rfr_iscdi=true |